01 Stock Market
As of Feb 6, the U.S. major indexes closed as follows… Dow Jones Industrial Average down 1.20% at 48,908.72; S&P 500 down 1.23% at 6,798.40; Nasdaq Composite down 1.59% at 22,540.59. Megacaps broadly retreated as investors digested heavier AI capital-expenditure plans and softer guidance across parts of tech, while crypto-exposed shares extended declines in tandem with digital-asset weakness.
Unusual-move stocks: Mega-cap and AI-adjacent names saw wide moves. Microsoft (MSFT) down 4.95% at $393.67; Amazon (AMZN) down 4.42% at $222.69; Oracle (ORCL) down 6.95% at $136.48; Coinbase (COIN) down 13.34% at $146.12; Palantir (PLTR) down 6.83% at $130.01; Tesla (TSLA) down 2.17% at $397.21; NVIDIA (NVDA) down 1.33% at $171.88; AMD (AMD) down 3.84% at $192.50. Select pockets diverged: Micron (MU) up 0.92% at $382.89; Meta (META) up 0.18% at $670.21; China EV ADR NIO (NIO) up 5.86% at $4.70.
Precious-metals proxies tumbled as silver sold off: iShares Silver Trust (SLV) down 15.77% at $66.69; leveraged silver fund ProShares Ultra Silver (AGQ) down 30.46% at $122.04. AI-software and crypto beta were weak while hedges firmed: Direxion Daily TSLA Bull 2X (TSLL) down 4.42% at $14.50; ProShares UltraPro Short QQQ (SQQQ) up 4.32% at $74.58. Semis-leverage was mixed: Direxion Daily Semiconductors Bull 3X (SOXL) up 0.11% at $53.25; Direxion Daily Semiconductors Bear 3X (SOXS) up 0.45% at $2.24. In healthcare, Novo Nordisk (NVO) down 8.16% at $43.34.
02 Other Markets
U.S. 10-year Treasury yield rose by 0.00%, latest at 4.21%.
USD/CNH rose 0.0000%, at 6.94; USD/HKD fell 0.0026%, at 7.81.
U.S. Dollar Index rose 0.0204%, at 97.96.
WTI crude futures fell 0.36%, at 63.06 USD/bbl; COMEX gold futures fell 2.27%, at 4,778.60 USD/oz.
03 Top News
Event-driven headlines after the close centered on capex, supply bottlenecks, healthcare competition, and labor signals.
1. Amazon announced a more than 50% increase in capital expenditures, and its shares tumbled. The company outlined plans to pour resources into AI infrastructure, including its Rainier project using in-house Trainium2 chips. Amazon’s operating-income outlook came in below some expectations, as higher network and retail investments weigh on near-term profitability.
2. Alphabet projected sharply higher AI capital spending, pressuring its stock despite strong cloud momentum. Management signaled capex could reach as high as the mid‑$100 billions range in the coming year as it scales data centers and AI. Investors focused on the timeline for returns from these investments even as core businesses remain solid.
3. Qualcomm issued a cautious outlook citing a memory shortage, sending the shares lower. The company’s guidance flagged supply constraints affecting near-term shipments and partners. Markets interpreted the forecast as a sign that tight memory availability could ripple across parts of the handset and device ecosystem.
4. NVIDIA is slashing production of GeForce RTX 50 gaming GPUs due to a memory shortage and will not release a new gaming chip in 2026. The move prioritizes scarce memory for higher-value uses and reflects tight component supply across the industry. The decision underscores ongoing constraints that may divert resources toward data center and AI products.
5. Tower Semiconductor announced a collaboration with NVIDIA on advanced silicon photonics for AI data centers, boosting its shares. The partnership targets 1.6T optical modules to accelerate next-gen networking performance. Tower said the platform can double data rates versus prior solutions, positioning it for growing AI infrastructure demand.
6. Hims & Hers launched a compounded version of Wegovy’s semaglutide pill at an introductory $49 price, intensifying weight-loss competition. The offering undercuts branded pricing and caters to patients preferring oral regimens, with subscription tiers scaling over time. Shares of Hims rose while Novo Nordisk faced pressure amid growing cash-pay and discount dynamics.
7. The U.S. FDA previously warned Hims over marketing of compounded semaglutide, highlighting regulatory scrutiny of copycat treatments. The notice flagged messaging that could imply equivalence with approved brands, which compounded products do not have. Hims emphasized it expanded its Ohio facility to lower costs and tailor treatments while working within regulatory frameworks.
8. The U.S. Department of Labor reported initial jobless claims rose to 231,000, signaling some cooling in the labor market. The print exceeded consensus estimates, adding to concerns around near-term employment momentum. Markets weighed whether softening labor signals could affect consumption and corporate hiring plans.
9. Challenger, Gray & Christmas reported U.S. employers announced 108,435 layoffs, the highest January total since the financial crisis. The firm’s data suggested companies are trimming headcount amid efficiency drives and shifting strategic priorities. This elevated layoff tally reinforced broader caution around the employment backdrop.
10. U.S. spot bitcoin ETFs saw their biggest inflows since early January this week even as bitcoin prices fell below key thresholds. ETF buyers stepped in on weakness, though cumulative flows in prior months were net negative. The mixed flow picture highlights ongoing volatility and divergent convictions across institutional and retail crypto participants.
Sources: Reuters, Dow Jones, Tiger Newspress, public market data
Disclaimer: This content is for reference only and does not constitute investment advice.
